ResMed Inc. (RMD) Financials
Key financial figures for ResMed Inc. (Q4 2026).
ResMed Q4 FY2026 revenue rose 9% YoY to $1.464B with non-GAAP diluted EPS up 16% to $2.95, while GAAP diluted EPS grew 2% to $2.64 on a $42M Astral field-safety charge. Revenue of $1.464B, up 9% YoY (8% constant currency) GAAP diluted EPS $2.64 (+2% YoY); non-GAAP diluted EPS $2.95 (+16% YoY) GAAP gross margin 58.8% (-200 bps YoY) entirely due to a $42M Astral ventilator field-safety notification expense; non-GAAP gross margin expanded 90 bps to 62.3% Devices revenue $750M (+8% YoY); Masks and other revenue $542M (+11% YoY); Residential Care Software (SaaS) revenue $172M (+3% YoY) Full fiscal year 2026: revenue $5.653B (+10%), non-GAAP diluted EPS $11.17 (+17%) Operating cash flow $455M in the quarter ($1.806B for FY2026); raised quarterly dividend 10% to $0.. Figures are for Q4 FY2026, as ResMed Inc. reported them.
- Revenue
- $1.5B
- Net Income
- $383M
- EPS
- $2.65
- Total Assets
- $9.0B
- Operating Cash Flow
- $455M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q4 FY2026 | $1.5B | $383M | $2.64 | 30.66% | $1.6B |
| Q3 FY2026 | $1.4B | $399M | $2.71 | 34.92% | $520M |
| Q2 FY2026 | $1.4B | $393M | $2.68 | 34.97% | $305M |
| Q1 FY2026 | $1.3B | $349M | $2.37 | 33.43% | $414M |
| Q4 FY2025 | $1.3B | $380M | $2.58 | 33.72% | $508M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2026 | $5.7B | $1.5B | $10.40 | 33.48% | $1.6B |
| FY2025 | $5.1B | $1.4B | $9.51 | 32.75% | $1.7B |
| FY2024 | $4.7B | $1.0B | $6.92 | 28.17% | $1.3B |
Frequently asked questions
What was ResMed Inc.'s revenue last quarter?
ResMed Inc. reported revenue of $1.46 billion for Q4 FY2026, up 8.6% from the same period a year earlier.
Is ResMed Inc. profitable?
Yes. ResMed Inc. reported net income of $383.4 million for Q4 FY2026, a net margin of 26.2% on revenue.
How has ResMed Inc.'s margin trended?
Operating margin was 30.66% in Q4 FY2026, compared with 33.72% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did ResMed Inc. generate?
ResMed Inc. generated free cash flow of $1.65 billion in Q4 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for ResMed Inc. on SentiSense, with up to forty quarters and twenty fiscal years of history.